Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII
Diana Crivellari, Marco Bonetti, Monica Castiglione-Gertsch, Richard D. Gelber, Carl Magnus Rudenstam, Beat Thürlimann, Karen N. Price, Alan S. Coates, Christoph Hürny, Jürg Bernhard, Jurij Lindtner, John Collins, Hans Jörg Senn, Franco Cavalli, John Forbes, Anne Gudgeon, Edda Simoncini, Hernan Cortes-Funes, Andrea Veronesi, Martin FeyAron Goldhirsch
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: The International Breast Cancer Study Group Trial VII'. Together they form a unique fingerprint.